English
 

All || Biopharma || Diagnostics and Life Science Tools || Medical Device || Healthcare IT || Healthcare Services || Exited

3SBio

Fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China

IPO in May 2015 (HKSE: 1530)

ARMO Biosciences

Late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors

Acquired by Eli Lilly in May 2018

Cellular Research

Life science tools company developing a next-generation single cell preparation technology

Acquired by Becton Dickinson in August 2015

Cirina

Diagnostics compaby based in Hong Kong and Silicon Valley developing proprietary plasma-based early cancer screening/detection utilizing next-generation sequencing

Acquired by GRAIL in May 2017

   
   

GeneWEAVE

Diagnostics company developing and commercializing products for bacterial susceptibility testing for surveillance of hospital acquired infections

Acquired by Roche in August 2015

Invitae

Genetic information company with a mission to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people

IPO in February 2016 (NASDAQ: NVTA)

   
Copyright © 2011 Decheng Capital LLC. All Rights Reserved.